Pablo Padilla, MD
Plastic and Reconstructive Surgery · Houston, TXNPI 1407205941
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Kerecis Limited at 54.0% of the total. 2025 is the largest year on record at $31,224, more than ten times the $724 reported in 2019. Among plastic and reconstructive surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $167.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$25K
- AbbVie$7K
- Axogen$5K
- Mentor Worldwide LLC$2K
- Stryker$1K
- Musculoskeletal Transplant Foundation Inc.$1K
- plus $5K from 33 others
What the payments were for
- Speaking & faculty fees$19,35042%
- Travel & lodging$6,96115%
- Food & beverage$19,29242%
- Other$3261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 31 | $24,808 |
| AbbVie(2 entities) | 66 | $6,774 |
| Axogen | 41 | $4,660 |
| Mentor Worldwide LLC | 26 | $1,917 |
| Stryker | 9 | $1,436 |
| Musculoskeletal Transplant Foundation Inc. | 9 | $1,299 |
| Integra Lifesciences Corporation | 14 | $944 |
| TELA Bio, Inc. | 8 | $563 |
| Acera Surgical, Inc. | 6 | $373 |
| Johnson & Johnson(2 entities) | 7 | $346 |
| Zimmer Biomet | 3 | $287 |
| Sientra, Inc. | 2 | $276 |
| Medline Industries LP | 4 | $249 |
| Coopersurgical, Inc. | 3 | $202 |
| Dilon Technologies, Inc. | 1 | $168 |
| Avita Medical Americas, LLC | 3 | $153 |
| Bard Peripheral Vascular, Inc. | 1 | $140 |
| Baxter Healthcare | 2 | $139 |
| Kls-martin L.p. | 1 | $125 |
| Aroa Biosurgery Incorporated | 10 | $122 |
| Heron Therapeutics, Inc. | 1 | $122 |
| Abbott | 1 | $93 |
| Tepha Inc | 1 | $93 |
| Smith+Nephew | 3 | $82 |
| Davol Inc. | 2 | $76 |
| RTI Surgical, Inc | 4 | $74 |
| Mimedx Group, Inc. | 2 | $59 |
| Medtronic | 2 | $52 |
| Bone Support Inc. | 1 | $50 |
| Urgo Medical North America, LLC | 2 | $37 |
| Motiva USA, LLC | 1 | $36 |
| Lifenet Health | 1 | $31 |
| KCI USA, Inc. | 1 | $26 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $20 |
| Solventum Corporation | 1 | $20 |
| Medical Device Business Services, Inc. | 1 | $19 |
| Alafair Biosciences, Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$96,419
- Kerecis GraftGuide$24,105
- AXOGUARD$3,072
- NATRELLE SALINE-FILLED BREAST IMPLANTS$2,951
- AXOGUARD HA+ NERVE PROTECTOR$2,421
- AxoGuard Nerve Cap$2,421
- AVANCE NERVE GRAFT$1,728
- Kerecis Omega3 Marigen$1,582
- ALLODERM$1,434
- MENTOR MemoryGel Resterilizable Gel Sizer$1,153
- 1788$1,043
- AxoGuard Nerve Connector$1,014
- AxoGuard Nerve Protector$1,014
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$397
- Kerecis Omega3 SurgiClose$395
- DuraSorb Monofilament Mesh$326
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$308
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$276
- Restrata Wound Matrix$272
- ARTOURA Breast Tissue Expander$272
How this compares
$45,929 in reported general payments places this provider in the 95th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 24 | $541 |
| Mupirocin | 28 | $176 |
| Gabapentin | 25 | $121 |
| Cephalexin | 19 | $108 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $44 |
| Tramadol Hcl | 16 | $20 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Houston
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
- Edward ChangHouston$111K
- Christi BlakkolbHouston$69K
- Justin BroylesHouston$48K
- Courtney El-ZokmHouston$29K
- John NguyenHouston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.